Index S&P 500
P/E 15.92
EPS (ttm) 8.00
Insider Own 0.67%
Shs Outstand 1.74B
Perf Week -4.52%
Market Cap 221.54B
Forward P/E 22.45
EPS next Y 5.67
Insider Trans -0.07%
Shs Float 1.73B
Perf Month -5.13%
Enterprise Value 227.96B
PEG 1.54
EPS next Q 1.49
Inst Own 80.07%
Short Float 1.05%
Perf Quarter 2.93%
Income 13.94B
P/S 5.05
EPS this Y 10.31%
Inst Trans 0.23%
Short Ratio 2.82
Perf Half Y -1.86%
Sales 43.84B
P/B 4.38
EPS next Y 10.08%
ROA 17.75%
Short Interest 18.17M
Perf YTD 12.53%
Book/sh 29.05
P/C 30.42
EPS next 5Y 10.34%
ROE 31.01%
52W High 141.23 -9.87%
Perf Year 8.56%
Cash/sh 4.18
P/FCF 32.70
EPS past 3/5Y 24.73% 29.98%
ROIC 21.95%
52W Low 110.86 14.82%
Perf 3Y 25.10%
Dividend Est. 2.38 (1.87%)
EV/EBITDA 21.28
Sales past 3/5Y -0.88% 5.63%
Gross Margin 58.38%
Volatility 2.21% 2.02%
Perf 5Y 16.09%
Dividend TTM 2.36 (1.85%)
EV/Sales 5.20
EPS Y/Y TTM 152.28%
Oper. Margin 17.75%
ATR (14) 2.93
Perf 10Y 209.25%
Dividend Ex-Date Oct 15, 2025
Quick Ratio 1.30
Sales Y/Y TTM 6.37%
Profit Margin 31.79%
RSI (14) 34.85
Recom 1.88
Dividend Gr. 3/5Y 7.17% 11.16%
Current Ratio 1.82
EPS Q/Q 0.17%
SMA20 -4.50%
Beta 0.70
Target Price 144.60
Payout 29.33%
Debt/Eq 0.27
Sales Q/Q 6.90%
SMA50 -3.93%
Rel Volume 1.12
Prev Close 129.45
Employees 114000
LT Debt/Eq 0.26
Earnings Oct 15 BMO
SMA200 -2.19%
Avg Volume 6.45M
Price 127.29
IPO Mar 01, 1937
Option/Short Yes / Yes
EPS/Sales Surpr. -0.21% -0.20%
Trades
Volume 5,576,753
Change -1.67%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-10-25 Initiated
The Benchmark Company
Buy
$145
Jul-18-25 Upgrade
Jefferies
Hold → Buy
$145
Jun-16-25 Initiated
Leerink Partners
Market Perform
$143
Oct-08-24 Initiated
Oppenheimer
Outperform
$130
Sep-19-24 Initiated
Piper Sandler
Overweight
$131
Jul-30-24 Downgrade
Edward Jones
Buy → Hold
May-30-24 Initiated
Goldman
Buy
$121
Jul-21-23 Upgrade
Wolfe Research
Underperform → Peer Perform
May-30-23 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$112
Apr-20-23 Reiterated
Wolfe Research
Underperform
$107 → $103
Apr-20-23 Reiterated
UBS
Buy
$117 → $130
Apr-20-23 Reiterated
Raymond James
Outperform
$116 → $123
Apr-20-23 Reiterated
JP Morgan
Overweight
$118 → $122
Apr-20-23 Reiterated
Bernstein
Outperform
$132 → $133
Apr-20-23 Reiterated
Barclays
Overweight
$125 → $127
Mar-29-23 Initiated
UBS
Buy
$117
Oct-26-22 Initiated
Mizuho
Neutral
$105
Oct-18-22 Initiated
Barclays
Overweight
$118
Oct-12-22 Initiated
Jefferies
Hold
$110
Jul-06-22 Initiated
Wolfe Research
Underperform
$95
Show Previous Ratings
Today 07:50AM
07:50AM
07:49AM
06:45AM
05:58AM
01:31AM
Loading…
01:31AM
Oct-15-25 04:20PM
04:16PM
04:09PM
(Investor's Business Daily)
04:06PM
03:06PM
03:01PM
02:10PM
01:43PM
12:15PM
11:40AM
Loading…
11:40AM
11:18AM
10:57AM
10:33AM
10:12AM
09:45AM
09:30AM
08:54AM
(Investor's Business Daily)
08:53AM
(Investor's Business Daily)
08:40AM
08:25AM
08:11AM
07:56AM
07:55AM
(The Wall Street Journal)
07:38AM
(Associated Press Finance)
07:30AM
Loading…
07:30AM
07:30AM
07:30AM
03:19AM
(The Wall Street Journal)
Oct-14-25 07:11PM
07:11PM
07:11PM
07:11PM
07:11PM
07:00PM
01:22PM
07:35AM
07:35AM
Oct-13-25 11:02PM
04:23PM
Oct-12-25 07:46AM
06:00AM
Oct-10-25 08:18PM
01:05PM
09:36AM
09:15AM
09:00AM
08:44AM
Oct-09-25 02:05AM
Oct-08-25 02:17AM
Oct-07-25 04:44AM
Oct-06-25 09:50AM
Oct-03-25 05:50PM
05:24PM
09:30AM
05:54AM
Oct-02-25 07:06AM
02:33AM
Oct-01-25 05:28PM
11:11AM
08:44AM
Sep-30-25 05:01PM
Sep-29-25 12:41PM
09:32AM
09:00AM
05:46AM
Sep-26-25 11:40AM
08:41AM
Sep-25-25 11:16AM
05:40AM
Sep-24-25 06:00PM
11:57AM
09:00AM
Sep-23-25 02:47PM
Sep-21-25 07:05PM
Sep-19-25 11:02AM
09:00AM
08:59AM
05:45AM
Sep-18-25 09:41PM
09:01AM
08:56AM
Sep-16-25 05:50PM
09:30AM
09:00AM
Sep-13-25 06:42AM
Sep-11-25 06:48PM
Sep-10-25 05:50PM
11:40AM
Sep-09-25 09:05AM
Sep-08-25 04:51PM
Sep-07-25 02:37PM
Sep-05-25 08:50AM
Sep-04-25 08:47AM
04:09AM
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the line of branded generic pharmaceuticals manufactured worldwide and marketed and sold outside the United States in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternate care testing sites. The Nutritional Products segment caters to the worldwide sales of pediatric and adult nutritional products. The Medical Devices segment includes a broad line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care and continuous glucose monitoring products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Boudreau Philip P EVP AND CFO Aug 08 '25 Sale 134.55 5,550 746,758 51,003 Aug 11 05:53 PM Boudreau Philip P Officer Aug 08 '25 Proposed Sale 134.55 5,550 746,758 Aug 08 06:30 PM Blount Sally E. Director Apr 30 '25 Sale 129.66 2,600 337,116 34,058 May 02 05:04 PM SALLY E BLOUNT Director Apr 30 '25 Proposed Sale 129.66 2,600 337,116 Apr 30 04:23 PM Earnhardt Lisa D EVP AND GROUP PRESIDENT Mar 06 '25 Option Exercise 80.98 91,167 7,382,704 163,095 Mar 07 06:55 PM Earnhardt Lisa D EVP AND GROUP PRESIDENT Mar 07 '25 Option Exercise 80.98 200 16,196 72,128 Mar 07 06:55 PM Earnhardt Lisa D EVP AND GROUP PRESIDENT Mar 06 '25 Sale 133.82 91,167 12,199,968 71,928 Mar 07 06:55 PM Earnhardt Lisa D EVP AND GROUP PRESIDENT Mar 07 '25 Sale 136.65 200 27,329 71,928 Mar 07 06:55 PM Lisa D. Earnhardt Officer Mar 07 '25 Proposed Sale 136.65 200 27,329 Mar 07 06:28 PM Lisa D. Earnhardt Officer Mar 06 '25 Proposed Sale 133.82 91,167 12,199,967 Mar 06 05:47 PM Wainer Andrea F RETIRED EVP Mar 03 '25 Sale 138.17 949 131,123 74,381 Mar 04 08:05 PM Shroff Eric Senior Vice President Mar 03 '25 Sale 138.17 562 77,652 31,970 Mar 04 08:00 PM Morrone Louis H. EXECUTIVE VICE PRESIDENT Mar 03 '25 Sale 138.17 1,111 153,507 66,878 Mar 04 07:49 PM Moreland Mary K EXECUTIVE VICE PRESIDENT Mar 03 '25 Sale 138.17 791 109,292 95,583 Mar 04 07:44 PM MCCOY JOHN A. JR. VICE PRESIDENT AND CONTROLLER Mar 03 '25 Sale 138.17 562 77,652 21,061 Mar 04 07:39 PM Eric Shroff Officer Mar 03 '25 Proposed Sale 138.17 562 77,651 Mar 03 08:40 PM Andrea F. Wainer Retired Officer Mar 03 '25 Proposed Sale 138.17 949 131,123 Mar 03 08:18 PM Louis H. Morrone Officer Mar 03 '25 Proposed Sale 138.17 1,111 153,506 Mar 03 08:08 PM Mary K. Moreland Officer Mar 03 '25 Proposed Sale 138.17 791 109,292 Mar 03 07:58 PM John A. McCoy, Jr. Officer Mar 03 '25 Proposed Sale 138.17 562 77,651 Mar 03 07:52 PM Ford Robert B CHAIRMAN AND CEO Feb 05 '25 Option Exercise 38.40 285,388 10,958,899 505,447 Feb 07 05:51 PM Ford Robert B CHAIRMAN AND CEO Feb 05 '25 Sale 131.17 285,388 37,435,200 220,059 Feb 07 05:51 PM Robert B. Ford Officer Feb 05 '25 Proposed Sale 131.17 285,388 37,435,238 Feb 05 06:52 PM ALLEN HUBERT L EXECUTIVE VICE PRESIDENT Jan 29 '25 Option Exercise 38.40 131,360 5,044,224 316,166 Jan 31 07:16 PM ALLEN HUBERT L EXECUTIVE VICE PRESIDENT Jan 30 '25 Option Exercise 38.40 58,428 2,243,635 243,234 Jan 31 07:16 PM ALLEN HUBERT L EXECUTIVE VICE PRESIDENT Jan 29 '25 Sale 128.35 131,360 16,859,675 184,806 Jan 31 07:16 PM ALLEN HUBERT L EXECUTIVE VICE PRESIDENT Jan 30 '25 Sale 128.07 58,428 7,482,629 184,806 Jan 31 07:16 PM Salvadori Daniel Gesua Sive EXECUTIVE VICE PRESIDENT Jan 30 '25 Option Exercise 38.40 23,771 912,806 149,468 Jan 31 07:08 PM Salvadori Daniel Gesua Sive EXECUTIVE VICE PRESIDENT Jan 30 '25 Sale 128.50 23,771 3,054,574 125,697 Jan 31 07:08 PM Morrone Louis H. EXECUTIVE VICE PRESIDENT Jan 28 '25 Sale 127.39 2,644 336,819 0 Jan 30 07:33 PM Hubert L. Allen Officer Jan 30 '25 Proposed Sale 128.07 58,428 7,482,628 Jan 30 05:33 PM Daniel Gesua Sive Salvadori Officer Jan 30 '25 Proposed Sale 128.50 23,771 3,054,573 Jan 30 05:26 PM Hubert L. Allen Officer Jan 29 '25 Proposed Sale 128.35 131,360 16,859,675 Jan 29 05:30 PM Funck, Jr. Robert E. Officer Nov 04 '24 Proposed Sale 120.00 15,000 1,800,000 Nov 04 04:02 PM ALLEN HUBERT L EXECUTIVE VICE PRESIDENT Oct 21 '24 Option Exercise 47.00 157,421 7,398,787 342,227 Oct 23 05:10 PM ALLEN HUBERT L EXECUTIVE VICE PRESIDENT Oct 21 '24 Sale 117.04 157,421 18,424,298 184,806 Oct 23 05:10 PM ALLEN HUBERT L Officer Oct 21 '24 Proposed Sale 118.89 157,421 18,715,783 Oct 21 04:08 PM